Microalbuminuria in Young Patients with Type 1 Diabetes

  • Henrik Bindesbøl Mortensen

Abstract

Diabetic nephropathy is the main cause of the increased morbidity and mortality among patients with Type 1 diabetes [1–3]. In recent years it has been shown that a slightly elevated urinary albumin excretion rate (microalbuminuria) is an early predictor for later development of manifest diabetic nephropathy [4–7]. The presence of hypertension in the diabetic individual markedly increases the risk and accelerates the course of the diabetic kidney disease [8–11]. Given the poor prognosis for patients developing manifest diabetic nephropathy emphasize the need for a uniform intervention programme for treatment of microalbuminuria in children and adolescents with Type 1 diabetes.

Keywords

Diabetic Nephropathy Blood Glucose Control Albumin Excretion Rate Diabetic Kidney Disease Urinary Albumin Excretion Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL. The Pittsburgh insulin-dependent diabetes mellitus (IDDM). Morbidity and mortality study. Mortality results. Diabetes 1984; 33: 271–276.PubMedCrossRefGoogle Scholar
  2. 2.
    Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in Type 1 (insulin dependent) diabetes mellitus. Diabetologia 1985; 28: 590–596.PubMedCrossRefGoogle Scholar
  3. 3.
    Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987; 294: 1651–1654.PubMedCrossRefGoogle Scholar
  4. 4.
    Mogensen CE, Damsgaard EM, Frøland A, Hansen KW, Nielsen S, Pedersen MM, Schmitz A, Thuesen L, Østerby R. Reduced glomerular filtration rate and cardiovascular damage in diabetes: a key role for abnormal albuminuria. Acta Diabetologia 1992; 29: 201–213.CrossRefGoogle Scholar
  5. 5.
    Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Nyberg G, Frahm Bjørn S, Hanssen KF. Early glomerulopathy is present in young, Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36: 523–529.PubMedCrossRefGoogle Scholar
  6. 6.
    Ellis EN, Pysher TJ. Renal disease in adolescents with Type 1 diabetes mellitus: A report of the southwest pediatric nephrology study group. Am J Kidney Dis 1993; 22: 783–790.PubMedGoogle Scholar
  7. 7.
    Viberti GC. Prognostic significance of microalbuminuria. Am J Hypertens 1994; 7: 69–72.Google Scholar
  8. 8.
    Epstein M, Sowers JR. Diabetes mellitus and Hypertension. Hypertension 1992; 19: 403–418.PubMedCrossRefGoogle Scholar
  9. 9.
    Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993; 306: 1235–1239.CrossRefGoogle Scholar
  10. 10.
    Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: A 10-year prospective study. Diabetic Med 1995; 12: 482–487.PubMedCrossRefGoogle Scholar
  11. 11.
    Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G, for the Italian Microalbuminuria Study Group. Arterial hypertension and microalbuminuria in IDDM: The Italian microalbuminuria study. Diabetologia 1994; 37: 1015–1024.PubMedCrossRefGoogle Scholar
  12. 12.
    Mortensen HB, Marinelli K, Nørgaard K, Main K, Kastrup KW, Ibsen KK et al. A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with Type 1 diabetes. Diabetic Med 1990; 7: 887–897.PubMedCrossRefGoogle Scholar
  13. 13.
    Rowe DJF, Hayward M, Bagga H, Betts P. Effect of glycaemic control and duration of disease on overnight albumin excretion in diabetic children. BMJ 1984; 289: 957–959.PubMedCrossRefGoogle Scholar
  14. 14.
    Davies AG, Postlethwaite, Price DA, Burn JL, Houlton CA, Fielding BA. Urinary albumin excretion in school children. Arch Dis Child 1984; 59: 625–630.PubMedCrossRefGoogle Scholar
  15. 15.
    Gibb DM, Dunger D, Levin M, Shah V, Smith C, Barratt TM. Early markers of the renal complications of insulin dependent diabetes mellitus. Arch Dis Child 1989; 64: 984–991.PubMedCrossRefGoogle Scholar
  16. 16.
    Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: An early marker of renal involvement in diabetes. 2 (1985–86); 9: 85–95.Google Scholar
  17. 17.
    Feldt-Rasmussen B, Microalbuminuria and clinical nephropathy in Type 1 (insulin-dependent) diabetes mellitus: Pathophysiological mechanisms and intervention studies. Dan Med Bull 1989; 36: 405–415.PubMedGoogle Scholar
  18. 18.
    Eshøj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24h urine collections in assessment of diabetic microalbuminuria. Diabetic Med 1987; 4: 531–533.PubMedCrossRefGoogle Scholar
  19. 19.
    Gibb DM, Shah V, Preece M, Barratt TM. Variability of urine albumin excretion in normal and diabetic children. Pediatr Nephrol 1989; 3: 414–419.PubMedCrossRefGoogle Scholar
  20. 20.
    Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JAH, Patel S & Tate VE. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol 1990; 32: 229–239.CrossRefGoogle Scholar
  21. 21.
    Blankestijn PJ, Derkx FHM, Birkenhäger JC, Lamberts SWJ, Mulder P, Verschoor L, Schalekamp MADH, Weber RFA. Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. J Clin Endocrinol Metab 1993; 77: 498–502.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiarelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 1995; 9: 154–158.PubMedCrossRefGoogle Scholar
  23. 23.
    Mathiesen ER, Saurbrey N, Hommel E, Parving H.-H. Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986; 29: 640–643.PubMedCrossRefGoogle Scholar
  24. 24.
    Nørgaard N, Storm B, Graa M, Feldt-Rasmussen B. Elevated albumin excretion and retinal changes in children with Type 1 diabetes are related to long-term poor blood glucose control. Diabetic Med 1989; 6: 325–328.PubMedCrossRefGoogle Scholar
  25. 25.
    D’Antonio JA, Ellis D, Doft BH, Becker DJ, Drash AL, Kuller LH, Orchard TJ. Diabetic complications and glycemic control. The Pittsburgh prospective insulin-dependent diabetes cohort study status report after 5 yr of IDDM. Diabetes Care 1989; 12: 694–700.PubMedCrossRefGoogle Scholar
  26. 26.
    Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian Type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 1049–1054.PubMedCrossRefGoogle Scholar
  27. 27.
    Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15–18.PubMedCrossRefGoogle Scholar
  28. 28.
    Dahlquist G, Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Pædiatr Scand 1987; 76: 795–800.PubMedCrossRefGoogle Scholar
  29. 29.
    Janner M, Eberhard Knill S, Diem P, Zuppinger KA, Mullis PE. Persistent microalbuminuria in adolescents with Type 1 (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Eur J Pediatr 1994; 153: 403–408.PubMedCrossRefGoogle Scholar
  30. 30.
    Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; 37: 483–490.PubMedCrossRefGoogle Scholar
  31. 31.
    Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ 1994; 309, 1608–1612.PubMedCrossRefGoogle Scholar
  32. 32.
    Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria — a longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 1309–1314.PubMedCrossRefGoogle Scholar
  33. 33.
    Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995; 44: 916–923.PubMedCrossRefGoogle Scholar
  34. 34.
    Mortensen HB, Hartling SG, Petersen KE, and the Danish study group of diabetes in childhood. A nation-wide cross-sectional study of glycosylated haemoglobin in Danish children with Type 1 diabetes. Diabetic Med 1988; 5: 871–876.PubMedCrossRefGoogle Scholar
  35. 35.
    Mortensen HB, Villumsen J, Vølund Aa., Petersen KE, Nerup J and The Danish Study Group of Diabetes in Childhood. Relationship between insulin injection regimen and metabolic control in young Danish Type 1 diabetic patients. Diabetic Med 1992; 9: 834–839.PubMedCrossRefGoogle Scholar
  36. 36.
    Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994; 23: 171–175.PubMedGoogle Scholar
  37. 37.
    Rossing P, Tarnow L, Nielsen FS, Boelskifte S, Brenner BM, Parving H-H. Short stature and diabetic nephropathy. BMJ 1995; 310: 296–297.PubMedCrossRefGoogle Scholar
  38. 38.
    Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study II. Diabetes 1990; 39: 1116–1124.PubMedCrossRefGoogle Scholar
  39. 39.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.CrossRefGoogle Scholar
  40. 40.
    Krolewski AS, Laffel LBM, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251–1255.PubMedCrossRefGoogle Scholar
  41. 41.
    Mortensen HB, Hougaard P, Ibsen KK, Parving H-H and The Danish Study Group of Diabetes in Childhood. Relationship between blood pressure and urinary albumin excretion rate in young Danish Type 1 diabetic patients: Comparison to Non-diabetic children. Diabetic Med 1994; 11: 155–161.PubMedCrossRefGoogle Scholar
  42. 42.
    Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673–689.PubMedCrossRefGoogle Scholar
  43. 43.
    Mogensen CE, Christensen CK, Christiansen JS, Boyle N, Pederson MM, Schmitz A. Early hyperfiltration and late renal damage in insulin-dependent diabetes. Pediatr Adolesc Endocrinol 1988; 17: 197–205.Google Scholar
  44. 44.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Damkjær Nielsen M. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 610–617.PubMedGoogle Scholar
  45. 45.
    Deckert T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria: implications for micro-and macrovascular disease. Diabetes Care 1992; 15: 1181–1191.PubMedCrossRefGoogle Scholar
  46. 46.
    Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 1990; 117: 39–45.PubMedCrossRefGoogle Scholar
  47. 47.
    Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33: 470–476.PubMedCrossRefGoogle Scholar
  48. 48.
    Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297: 1092–1095.PubMedCrossRefGoogle Scholar
  49. 49.
    Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81–87.PubMedCrossRefGoogle Scholar
  50. 50.
    Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ 1993; 306: 175–182.PubMedCrossRefGoogle Scholar
  51. 51.
    Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275–279.PubMedCrossRefGoogle Scholar
  52. 52.
    Breyer JA, Hunsicker LG, Bain RP, Lewis EJ, and The Collaborative Study Group. Angiotensin converting enzyme inhibition in diabetic nephropathy. Kidney Int 1994; 45: 156–160.Google Scholar
  53. 53.
    Mathiesen ER, Rønn B, Jensen T, Storm B, Deckert T. Relation between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990; 39: 245–249.PubMedCrossRefGoogle Scholar
  54. 54.
    Zusman RM. Renin-and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney Int 1984; 25: 969–983.PubMedCrossRefGoogle Scholar
  55. 55.
    Anderson S, Brenner BM. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations: Diabetes Metab Rev 1988; 4: 163–177.PubMedCrossRefGoogle Scholar
  56. 56.
    Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension. Arch Intern Med 1984; 144: 1441–1444.PubMedCrossRefGoogle Scholar
  57. 57.
    Mirkin BL, Newman TJ. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group. Pediatrics 1985; 75: 1091–1100.PubMedGoogle Scholar
  58. 58.
    Shield JPH. Microalbuminuria and nephropathy in childhood diabetes. Practical Diabetes 1994; 11: 146–149.CrossRefGoogle Scholar
  59. 59.
    Shield JPH, Hunt LP, Karachaliou F, Karavanaki K, Baum JD. Is microalbuminuria progressive? Arch Dis Childhood 1995; 73: 512–514.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Henrik Bindesbøl Mortensen
    • 1
  1. 1.Pediatric DepartmentAmtssygehuset i GlostrupGlostrupDenmark

Personalised recommendations